In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vital Signs buys fluid warming company:

This article was originally published in Clinica

Executive Summary

Anaesthesia breathing systems manufacturer Vital Signs has bought blood warming technology specialist Enginivity in a deal worth $5.9m. The deal sees Totowa, New Jersey-based Vital Signs acquire the enFlow device, a fluid warming system that brings the warming element closer to the patient, reducing heat loss and post-operative infections. The enFlow device will be introduced to market in November, and provides the company with an entry into what it claims is a $40-45m domestic market. Enginivity (Lexington, Massachusetts) sold its FDA-cleared and CE-marked products to hospitals and the US government but received no revenue in 2006.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts